Omega-3 PUFA Intake May Be Protective Against Myopia
By Elana Gotkine HealthDay Reporter
MONDAY, Aug. 25, 2025 -- Omega-3 polyunsaturated fatty acid (ω-3 PUFA) intake may be protective against myopia in children, according to a study published online Aug. 19 in the British Journal of Ophthalmology.
Xiu Juan Zhang, from The Chinese University of Hong Kong, and colleagues conducted an analysis including 1,005 Chinese children aged 6 to 8 years from a population-based Hong Kong Children Eye Study. A validated food-frequency questionnaire was used to assess diet. An autorefractometer was used to assess cycloplegic spherical equivalent (SE) refraction, and axial length (AL) was measured through noncontact partial-coherence laser interferometry.
The researchers found that after adjustment for age, sex, body mass index, near-work time, outdoor time, and parental myopia history, AL was longest in the lowest versus the highest quartile group of ω-3 PUFA intake (adjusted mean, 23.29 versus 23.08 mm). Corresponding trends were observed in SE (–0.13 and 0.23 D in the lowest and highest groups, respectively). In contrast, the longest AL was seen in the highest versus the lowest quartile group of saturated fatty acids intake (23.30 versus 23.13 mm, respectively). The corresponding trends in SE were –0.12 and 0.13 D in the highest and lowest quartile groups, respectively. There was an association for lower ω-3 PUFA intake with myopia. No other associations were seen for nutrients with SE, AL, or myopia.
"Lower ω-3 PUFA intake in diet was significantly associated with myopia and AL elongation, indicating that ω-3 PUFA intake may play a protective role in myopia development in children," the authors write.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted August 2025
Read this next
FDA Approves Vizz Eye Drops to Improve Near Vision in Adults
TUESDAY, Aug. 5, 2025 -- The U.S. Food and Drug Administration has approved Vizz 1.44 percent (aceclidine ophthalmic solution) for the treatment of presbyopia in adults. Vizz is...
Corticosteroids Not Superior to Placebo for Add-On Treatment of Bacterial Keratitis
MONDAY, July 28, 2025 -- For the treatment of bacterial keratitis, adjunctive corticosteroids are not superior to placebo and adjunctive corneal cross-linking (CXL) is associated...
Indicators of Neuropathic Ocular Pain Identified After LASIK
TUESDAY, July 22, 2025 -- In a study published in the August issue of the American Journal of Ophthalmology, diagnostic indicators are identified for confirming chronic...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.